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We have examined the effects of interferon (IFN)-a/b on HIV-1 and SIV replication in CD4/ T-cell lines. To enable us to
examine these effects on a single cycle of virus replication, cells were synchronously infected with HIV-1 LAI or SIV mac251.
Cell lines included MT4 cells which were responsive to IFN and, as controls, C8166 cells which failed to respond to
interferon treatment. Similar to previous reports, we found that replication of both HIV-1 and SIV was markedly inhibited in
responsive MT4 cell lines treated with IFN. No such decreases were observed in HIV-1-infected, IFN-treated C8166 cells.
Levels of both intracellular and extracellular viral antigens decreased in both HIV-1- and SIV-infected MT4 cells treated
with IFN. Whereas steady state levels of viral-specific RNAs dramatically declined in SIV-infected cells, no such decrease
was observed in IFN-treated HIV-1-infected cells. In accordance with these data, the rate of viral protein synthesis did not
significantly change in HIV-1-infected, IFN-treated MT-4 cells. Western blot analysis of extracts prepared from IFN-treated
HIV-1-infected cells revealed a decreased accumulation of most HIV-1-specific glycoproteins and proteins with the exception
of the pr55 gag precursor. Pulse–chase experiments confirmed the enhanced stability of pr55 in IFN-treated cells, but also
unexpectedly demonstrated the accelerated and quantitative processing of the p26 precursor (p24 capsid [CA] plus p2) to
the final processed p24 (CA) polypeptide. These data, taken together, suggest that IFN deregulated viral protein processing
and caused reduced protein stability in HIV-1-infected cells while inhibiting an earlier stage of replication in SIV-infected
cells. q 1995 Academic Press, Inc.
INTRODUCTION 30 additional IFN-induced genes most of which are still
uncharacterized (Sen and Lengyel, 1992).
It is well established that the interferon (IFN) arm of Indeed, there are numerous reports on interferon’s pro-
the host defense system is responsible, in part, for foundly negative effects on HIV-1 infection. There are a
blocking viral infection (Staehli, 1990; Samuel, 1991; Sen vast number of communications which detail the inhibi-
and Lengyel, 1992). Exactly how this occurs is incom- tion of HIV replication in both chronically and acutely
pletely understood although several interferon-induced infected cells (reviewed in Laurence, 1990; Pitha, 1991,
gene products have been identified which have antiviral 1994) although similar reports examining effects of IFN
properties. These include the dsRNA-activated protein treatment on SIV infection are noticeably lacking. Blocks
kinase, PKR, the 2*-5* oligoadenylate synthetase, RNAse to both early and late stages of HIV-1 replication have
L, and the Mx proteins (Staehli, 1990; Hovanessian, 1991; been reported (Poli et al., 1989; Smith et al., 1991; Meylan
et al., 1993; Shirazi and Pitha, 1993, 1995; Coccia et al.,Zhou et al., 1993; Katze, 1995). These proteins can inter-
1994; Baca-Regen et al., 1995). For example, it has beenfere with multiple levels of viral gene expression, ranging
shown that IFN can block both the assembly and releasefrom the inhibition of viral mRNA transcription and trans-
of virions in promonocytic cells, T cell lines chronicallylation to the degradation of viral mRNAs. Viruses have
infected by HIV-1, and peripheral blood T cells acutelynecessarily evolved mechanisms to avoid the negative
infected with virus at a low multiplicity of infection (Polieffects on replication imposed by select IFN-induced
et al., 1989; Fernie et al., 1991; Perno et al., 1993; Hansengene products (reviewed in Katze, 1992, 1993; Samuel,
et al., 1995). In contrast there are many studies which1993). Particularly well understood are the strategies em-
demonstrate an IFN-induced block to earlier stages ofployed to inhibit PKR, the dsRNA-activated protein ki-
replication. Pitha and colleagues and Gendelman andnase. Employment of these PKR regulatory mechanisms
coworkers have presented convincing evidence that IFNdoes not, however, necessarily render viruses refractory
treatment results in dramatic decreases in proviral DNAto the antiviral effects of IFN since there are well over
accumulation and interferes with the initiation of HIV-1
reverse transcription (Shirazi and Pitha, 1993, 1995;
Baca-Regen et al., 1995). In a recent report, Coccia et1 To whom correspondence should be addressed. Fax: (206) 685-
0305. al. (1994) reported on a novel type of inhibition by IFN:
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decreases in HIV replication due to viral-specific mRNA Viable cells (2 1 106) were metabolically labeled as
described previously (Agy et al., 1990, 1991) and Tritontranslational blocks.
To complement our earlier studies, which were de- X-100 extracts prepared as described above. Immuno-
precipitation of [35S]methionine-labeled proteins from thesigned to explore the limited mechanisms employed by
HIV-1 to evade the antiviral effects of IFN (Roy et al., extracts was performed by reacting the lysate with HIV-
1-pooled antiserum (Agy et al., 1990, 1991). The precipi-1990, 1991), we attempted to systematically analyze the
molecular blocks on replication induced by IFN. We also tated proteins were denatured in protein disruption buffer
and electrophoresed on 14% SDS–PAGE. Antigen cap-examined, in parallel, effects on replication of the related
but distinct simian virus, SIV. We chose to perform these ture assays were commercial kits: HIV-1-Abbott polyva-
lent HIVAG-1 assay and SIV-Coulter, monoclonal anti-studies on MT4 cells which could be synchronously in-
fected with either HIV-1 or SIV viruses (Agy et al., 1990, p27 assay.
1991) to examine IFN effects on a single cycle of viral
replication. Although IFN dramatically reduced the repli- RNA analysis
cation of both these primate lentiviruses, we unexpect-
Total RNA was isolated from cells by the single-stepedly found dramatic differences in the stages of viral
guanidinium thiocyanate-phenol-chloroform extractiongene expression adversely affected. Whereas IFN
method previously described by Chomczynski and Sac-blocked an early step in SIV replication, possibly at the
chi (1987). For Northern blot analysis, RNA was electro-reverse transcription or proviral integration stage, HIV
phoresed on a 1% formaldehyde agarose gel which wasgene expression was disrupted at a later point. Both
transferred to nitrocellulose filters as described bythe stability and proteolytic processing of HIV-1-specific
Thomas (1980). Filters were probed with either the 32P-proteins were altered in IFN-treated cells.
labeled HIV-1 ARV DNA or cellular DNA clones (actin
and GAPDH; ATCC) prepared by random priming (Fein-
MATERIALS AND METHODS berg and Voglestein, 1983).
Cells, virus infections, and interferon treatment
RESULTS
MT4 (Harada et al., 1985) and C8166 (Salahuddin et
al., 1983) cells were obtained from the AIDS Reagent Interferon treatment inhibits the accumulation of HIV-
1 viral antigensrepository. HIV-1, strain LAI (Barre-Sinoussi et al., 1983;
Wain-Hobson et al., 1991), was propagated on CEM cells
To ensure that we were examining primary and notas described previously (Agy et al., 1990, 1991). SIV
secondary effects of IFN treatment, it was necessary tomac251 (Daniel et al., 1985) was propagated in MT4 cells
achieve a synchronous infection by both HIV-1 and SIVin a like manner. The resulting stocks were titrated by
viruses. Infecting cells at a high multiplicity of infectionlimiting dilution and added to the cells for 1 hr at 377 at
enabled us to examine IFN effects on a single cycle ofan m.o.i. of 0.01 TCID50/cell. The cells were washed free
virus infection. Rigorous proof required that virus replica-of unattached virus and placed in culture at 11 106 cells/
tion was refractory to AZT treatment if the drug wereml. Cells were treated with interferon (a/b) at 1000 units/
added shortly after viral infection (Coccia et al., 1994).ml culture 16 hr before virus infections. Analyses were
Since AZT inhibits reverse transcription, this would tellmainly performed at Days 2 and 3 postinfection (p.i.) for
us that additional rounds of infection were not occurringHIV-1 or 3 and 4 days p.i. for SIV when indirect immuno-
and that all cells were infected by the input virus. Whenfluorescence revealed that nearly 100% of the cells were
AZT (5 mM ) was added at 24 hr postinfection, HIV or SIVinfected.
infection of MT4 cells was only modestly reduced as
measured by viral antigen accumulation at 2 and 3 daysProtein analysis
postinfection, respectively (data not shown). We con-
firmed that this concentration of AZT completely blockedFor Western blot analysis, extracts were prepared from
cells which were first washed in PBS and disrupted in virus replication when added prior to infection. As con-
trols for the specificity of IFN action in the experimentsice-cold Triton X-100 lysis buffer (1% Triton X-100, 10 mM
Tris–HCl, pH 7.5, 50 mM KCl, 1 mM dithiothreitol, 2 mM to follow, we selected a CD4-positive T cell line that was
similar to MT4 cells, but which was refractory to IFNEDTA, 1 mM MgCl2 , 0.2 mM phenylmethanesulfonylfluor-
ide (PMSF), and 100 mg/ml aprotinin). For each blot, cell treatment. A further prerequisite was that both of these
cell lines be efficiently infected by both HIV-1 and SIVextracts were electrophoresed on 14% SDS–acrylamide
gels and transferred to nitrocellulose filters. The filters (Agy et al., 1990, 1991). For these purposes, the HTLV-
1-transformed C8166 cells were selected (Salahuddin etwere incubated with primary antibody (either pooled sera
from HIV-1-infected patients or SIV-infected macaques al., 1983). One proof that C8166 cells were nonresponsive
to IFN treatment required that IFN-induced genes not beor monoclonal antibodies to p24 or human actin). Bound
conjugated antibodies were detected by enhanced induced. Western blot analysis confirmed that a repre-
sentative IFN-induced gene, that encoding the dsRNAchemiluminescence (ECL).
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FIG. 1. Interferon treatment reduces the accumulation of intracellular and extracellular viral antigens in HIV-1 infected MT4 cells. MT4 cells were
mock pretreated or pretreated with 1000 U/ml IFN a/b for 16 hr and infected by HIV-1. At the indicated times, a polyvalent ELISA assay was
performed to measure either extracellular (A) or intracellular (B) viral-specific antigen (pg/ml) accumulation. As control, levels of extracellular viral
antigens were measured after HIV-1 infection of C8166 cells treated in the presence or absence of IFN (C).
activated protein kinase, PKR, was readily detected after (Fig. 2B). These data confirmed that IFN treatment
caused a dramatic reduction in p24 and p41 gag proteins,IFN treatment of MT4 cells but could not be detected in
C8166 cells even after treatment with 5000 units/ml of again only in MT4 cells. Curiously, levels of the pr55
precursor gag protein remained essentially unchanged,interferon-a/b (data not shown).
In the initial series of studies we examined viral anti- suggesting that proteolytic processing may be inhibited
gen accumulation in HIV-1 MT4-infected cells treated by IFN treatment (see below).
with 1000 units/ml interferon-a/b for 16 hr prior to infec- The decreases in HIV-1 gag and envelope protein lev-
tion. IFN treatment resulted in a 50-fold decrease in the els also may result from decreases either in protein syn-
accumulation of extracellular viral antigens in the super- thetic rates or viral-specific RNA levels. We therefore
natant at 2 days postinfection as detected by a polyvalent examined the effects of IFN on the efficiency of viral
ELISA antigen capture assay (Fig. 1A). Similarly, there mRNA translation in HIV-1-infected MT4 and C8166 cells
was a 30-fold decrease in the accumulation of intracellu- (Fig. 3A). Virus-infected cells were pulse-labeled with
lar HIV-1 viral antigens (Fig. 1B). To test if decreases in [35S]methionine for 2 hr at 2 days postinfection. Extracts
viral protein levels were due specifically to the effects of were prepared and subjected to immunoprecipitation
IFN and resultant induction of IFN-induced genes, an analysis using pooled antiserum from HIV-1-infected in-
identical experiment was performed with HIV-1-infected dividuals. While there were modest decreases in the
C8166 cells. In contrast to the MT4 cells, IFN had only rates of viral protein synthesis in HIV-1-infected MT4
modest effects on extracellular HIV-1 antigen accumula- cells treated with interferon, the decreases were not as
tion in virally infected C8166 cells (Fig. 1C). Thus IFN dramatic as the IFN-induced declines in protein accumu-
specifically inhibits both intracellular and extracellular lation and were likely mainly due to decreased stability
viral antigen accumulation, only in HIV-1-infected MT4 as discussed below. It is also important to note that
cells. levels of the p26 precursor protein (CA / p2) were re-
duced by IFN treatment especially if one compares levels
Analysis of viral specific gene expression in HIV-1 of p26 to the final cleavage product, p24. As expected
infected cells treated with interferon for the control set of experiments, there were no effects
of IFN treatment on viral protein synthesis rates in HIV-To examine the effects of IFN on the accumulation of
1-infected C8166 cells. To determine if viral RNA accumu-specific HIV-1 viral proteins, Western blot analysis was
lation was adversely affected by IFN treatment, Northernperformed on extracts from mock-infected and HIV-1-
blot analysis was performed on total cellular RNAs pre-infected MT4 and C8166 cells treated with IFN using
pared from HIV-1-infected MT4 cells treated with IFNpooled antisera from HIV-1-infected individuals (Fig. 2A).
(Fig. 3B). There were no decreases in the 3 major HIV-There was a dramatic reduction in the level of viral pro-
specific RNA species. These data, taken together, showteins, including envelope- and gag-specific products in
that the previously observed declines in viral protein lev-extracts prepared from MT4 cells infected with HIV-1 for
els cannot be attributed to declines in protein synthetic2 days in the presence of IFN. A notable exception was
rates or mRNA levels.the precursor gag protein, pr55, which was still detect-
To determine, therefore, whether decreases in viralable in IFN-treated cells. In contrast, IFN had no effects
protein accumulation were due, at least in part, to disrup-on viral protein accumulation in HIV-1-infected C8166
tion of polyprotein processing, a pulse–chase experi-cells as predicted from previous experiments. To more
ment was executed. At 2 days post HIV-1 infection in thecarefully look at the accumulation of gag-specific pro-
presence (Fig. 4A) or absence (Fig. 4B) of 1000 units/teins in extracts from IFN-treated cells, a duplicate blot
was probed with a p24-specific monoclonal antibody ml IFN, MT4 cells were pulse-labeled for 30 min with
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FIG. 2. Western blot analyses of IFN-treated HIV-1-infected MT4 and C8166 cell extracts. MT4 or C8166 cells were infected by HIV-1 or mock
infected and treated with IFN as indicated on top of the panel. Extracts were prepared and analyzed by Western blot. Duplicate blots were probed
either with pooled antisera from HIV-1-infected individuals (A) or with a p24-specific monoclonal antibody (B). Molecular weight markers (1103) are
shown on the left of each panel and the position of specific viral proteins on the right of each panel. To control for protein loading, each blot was
stripped and reprobed with a b actin-specific monoclonal antibody as shown at the bottom of each panel.
[35S]methionine. Cells were then washed and medium subjected to immunoprecipitation analysis with pooled
antisera. Several conclusions were reached from thiswith excess cold methionine was added. Extracts were
prepared after the 30-min pulse (lane 1), and at 2 (lane experiment: (i) There does not appear to be an IFN-in-
duced defect in the processing of the gp160 envelope2), 4 (lane 3), and 8 (lane 4) hr during the chase and
FIG. 3. Analysis of viral-specific protein synthetic rates and viral RNA accumulation in IFN-treated HIV-1-infected MT4 cells. (A) Radioimmunoprecipi-
tation analysis of mock- and HIV-1-infected C8166 and MT4 cells either IFN treated (1,000 U/ml) or untreated as shown at the top of the panel.
Cells were labeled with [35S]methionine for 2 hr after which cell extracts were prepared and subjected to immunoprecipitation utilizing pooled
antisera from HIV-1-infected individuals as described under Materials and Methods. Position of molecular weight standards are shown on the left
and viral-specific proteins on the right of the panel. (B) Northern blot of RNA prepared from mock- and HIV-1-infected MT4 cells either IFN-treated
(1,000 U/ml) or untreated (as shown at the top of the panel). Total RNA from HIV-infected MT4 cells was resolved on a formaldehyde agarose gel,
blotted onto a nitrocellulose membrane, and probed with a [32P]CTP-labeled HIV-1-specific DNA probe. Prominent viral RNAs are indicated by the
arrows on the left and the position of 18S and 28S rRNAs is shown on the right.
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precipitation analysis). To summarize, the data suggest
that IFN treatment destabilized viral proteins in addition
to interfering with the proper processing of the gag pre-
cursor proteins.
Interferon blocks SIV replication at an early stage of
infection
In contrast to HIV-1, little is known about the effects
of IFN on SIV replication. However, as with HIV-1, we
were able to demonstrate that both extracellular and in-
tracellular viral antigen production was greatly dimin-
ished in SIV synchronously infected MT4 cells treated
with IFN-a/b (data not shown). To examine the specific
level of viral gene expression affected, we performed
Western blot analysis on MT4 extracts prepared from
cells infected with SIV mac251 for 3 days and treated
FIG. 4. Pulse-chase analysis of IFN-treated HIV-infected MT4 cells.
with IFN. This was accomplished using pooled antiseraMT4 cells were infected by HIV-1 in the presence (A) or absence (B)
from SIV-infected macaques. Identical to the HIV-1/IFNof IFN as described under Materials and Methods. At Day 2 postinfec-
tion, cells were pulse-labeled with [35S]methionine for 30 min. The experiments, we found a dramatic decrease in the accu-
label was then removed and media containing an excess of unlabeled mulation of essentially all SIV proteins (Fig. 5A). To di-
methionine was added. Extracts were prepared immediately after the rectly determine if these decreases were due to reduc-
pulse (lanes 1) or at 2 hr (lanes 2), 4 hr (lanes 3), or 8 hr (lanes 4)
tions in SIV RNA accumulation, Northern blot analysisduring the chase period. The extracts were then subjected to immuno-
was performed on total RNA extracted from cells infectedprecipitation analysis using pooled HIV antisera and the radiolabeled
viral proteins resolved by SDS – PAGE. Positions of molecular weight with SIV for 3 days (Fig. 5B). In contrast to the HIV-1
standards are shown on the left and representative viral proteins on RNA experiments described above, there was a dramatic
the right. reduction in the levels of viral RNA caused by IFN treat-
ment, suggestive of an early block to SIV replication.
glycoprotein to gp120. However, in the presence of IFN
DISCUSSION
there were more rapid declines in the levels of gp160
and gp120 such that by 8 hr, glycoprotein levels were In the present report we analyzed the antiviral effects
barely detectable compared to controls, thus confirming of interferon-a/b on the replication of both SIV mac251
the earlier Western blot analysis. (ii) Processing of the and HIV-1 LAI in synchronously infected MT4 cells.
gag precursor, pr55, was reduced or slowed in IFN- Whereas early stages of SIV infection were inhibited, it
treated cells; in the absence of IFN, the label was com- was the later stages of HIV-1 viral-specific gene expres-
pletely chased out of pr55 by 4 hr while in the presence sion which were most disrupted. One can only speculate
of IFN there was still label present in pr55 at 8 hr post- as to why these closely related lentiviruses were inhib-
chase. (iii) In the absence of IFN there was a predomi- ited at such different stages of expression. One possibil-
nant p26 protein radiolabeled during the 30-min pulse. ity is that the differences are due to the IFN-specific
This likely represents CA / p2 which is the immediate targetting of an HIV-1-specific gene such as vpu, which
precursor to the final cleavage product, p24 (CA) (Pettit is unique to this virus. In this respect it will be informative
et al., 1994). Subsequently the p26 protein was chased to examine the effects of IFN on the replication of HIV-
into the mature p24 protein such that there were approxi- 2 which is more closely related to SIV. Another possibility
mately equimolar amounts of the two proteins throughout is that IFN is negatively effecting the action of the vif
the period. (iv) In contrast, in the presence of IFN there regulatory protein which has recently been shown to play
were already equimolar amounts of p26 and p24 synthe- a role in gag protein processing (Simm et al., 1995). Previ-
sized during the 30-min labeling period. Subsequently ous studies on SIV and IFN have largely focused on the
nearly all the label was chased into the mature p24 poly- effects of IFN in SIV-infected monkeys and the effects of
peptide with little p26 remaining. Based on the previous IFN-g in cell culture and have not attempted to carefully
Western data (Fig. 2), it was somewhat unexpected that define the relevant molecular interactions in any detail.
p24 appeared to remain stable during the 8-hr chase In fact there are two conflicting reports regarding the
period. It is tempting to speculate, therefore, that IFN effects of IFN-g on SIV replication. One report claimed
treatment may have also induced a posttranslational al- that IFN decreased SIV replication in macrophages while
teration on the p24 protein. Such a modification of an the other group actually reported an enhancement of
immunodominant epitope could conceivably enhance the replication in IFN-g-treated HuT-78 cells (Lairmore et al.,
reactivity of p24 with its specific antibody, particularly 1991; Walsh et al., 1991).
In terms of the more widely studied HIV-1, there seemswhen p24 is analyzed in its native form (i.e., by immuno-
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creases in protein stability which occurred during the
longer labeling period. The differences between our data
and others potentially can be due to virus strain or cell
line differences. It is also possible that many HIV-1 stud-
ies examined secondary effects of IFN treatment since
it is difficult to achieve a synchronous infection with
these lentiviruses.
We did observe a disruption of HIV-1 gene expression
at many other levels in the present study. Western blot
analysis revealed dramatic declines in the levels of
nearly all viral glycoproteins and gag-related proteins
with the exception of the gag precursor pr55. It is tempt-
ing to contemplate that IFN may be inducing a cellular
protease which specifically degrades viral proteins in-
cluding gp120. Although IFN does induce specific ribo-
nucleases (Samuel, 1991; Zhou et al., 1993), there is no
evidence to date that such a protease exists. Alterna-
tively, the intracellular trafficking of gp160 may be im-
paired by IFN leading to its rapid degradation. The en-
hanced stability of the pr55 precursor together with the
decreased accumulation of the p24 capsid protein origi-
nally suggested to us that proteolytic cleavage was inhib-
ited during IFN treatment. This observation led to the
FIG. 5. IFN treatment reduces the accumulation of viral proteins and pulse–chase studies which demonstrated the reduced
RNAs in SIV-infected cells. (A) Western blot analysis of mock- and SIV-
processing of pr55 during the chase period. However,infected MT4 cells either IFN-treated (1,000 U/ml) or untreated (shown
synthesis of the p24 protein was not decreased as pre-at the top of the panel). Extracts were prepared at 3 days postinfection
and subjected to Western analysis using pooled antisera from SIV- dicted. Paradoxically, despite the apparent decrease in
infected macaques. Molecular weight markers are shown on the left overall pr55 processing, there was an accelerated cleav-
and representative viral proteins on the right. The lower portion of the age involving the final step of the proteolytic pathway,
panel shows the same blot after stripping and reprobing with anti-actin
the cleavage of p26 (CA / p2) to p24 (CA) (Pettit et al.,monoclonal antibody to control for protein loading. (B) Northern blot
1994). These data also suggest that only a fraction ofanalysis of SIV-specific RNA. Total RNA, prepared from SIV-infected
MT4 cells at Day 3 (treated or untreated with IFN as indicated), was pr55 is successfully processed into its final product.
resolved on a formaldehyde agarose gel, blotted onto a nitrocellulose Swannstrom and colleagues recently found that the p2
membrane, and probed with [32P]CTP-labeled SIV-specific pBK28 DNA domain of the HIV-1 gag precursor regulates the rate of
probe. Prominent viral RNAs are indicated by the arrows on the left
cleavage of the CA/p2 site during sequential processingand the position of 18S and 28S rRNAs on the right. The lower portion
in vitro and in infected cells (Pettit et al., 1994). Moreover,of the panel shows the same blot after stripping and reprobing with
two representative actin and GAPDH cellular gene probes to control these investigators found that a deletion that removes
for RNA loading. the p2 domain resulted in accelerated cleavage at the
CA/p2 site. This prompted the conclusion that the pres-
ence of the p2 tail on processing intermediates may neg-
to be an emerging consensus that early blocks to HIV-1 atively regulate the rate of cleavage. It may be possible,
replication are mainly due to inhibition of reverse tran- therefore, that IFN treatment interferes with the normal
scription leading to defects in proviral DNA synthesis downregulation of cleavage by p2. One resulting sce-
(Shirazi and Pitha, 1993, 1995; Baca-Regen et al., 1995). nario is that the aberrantly high ratio of mature p24 to
We did not observe such an IFN-induced block to HIV-1 precursor p26 triggers the degradation of the capsid pro-
replication in our studies. Nor did we detect any de- tein by as yet undefined cellular mechanisms.
crease in the release or assembly of virions as has been To our knowledge this is the first report showing that
observed in other studies on the effects of IFN on retrovi- IFN treatment negatively effects virus replication at the
rus replication (Poli et al., 1989). We consistently found level of processing and stability. It is important to cite
that both extracellular and intracellular levels of viral anti- a recent report, however, which examined the effect of
gen were reduced in IFN-treated cells, suggesting that interleukin-10 (IL-10) on HIV-1 replication in primary
viral release per se was not inhibited. We also did not monocyte-derived macrophages. Kootstra et al. (1994)
detect a significant block to viral mRNA translation (Coc- showed by Western blot analysis that there was an ab-
cia et al., 1994). Although there were reductions in protein sence of mature p24 and gp120 viral proteins, but not
synthetic rates when infected cells were labeled for 2 hr the pr55 gag precursor protein in HIV-1-infected cells
(Fig. 3A), no such decrease was found in a 30-min pulse treated with IL-10. It was suggested that there may be a
defect in processing. However, until pulse-chase experi-(Fig. 4), suggesting any decreases were due to de-
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immunodeficiency virus type 1-infected monocytes. J. Virol. 68, 7559–ments are performed, it would be premature to conclude
7565.that IL-10 and interferon-a/b inhibit HIV-1 replication by
Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret,
similar mechanisms. In this regard it might be informative S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux,
to examine IL-10 levels in our HIV-1-infected cultures that C., Rozenbaum, W., and Montagnier, L. (1983). Isolation of a T-lym-
photropic retrovirus from a patient at risk for acquired immune defi-are treated with IFN.
ciency syndrome (AIDS). Science 220, 868–871.Cells have evolved complex host defense mechanisms
Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNAto combat virus infection. One of the major components
isolation by guanidium thiocyanate-phenol-chloroform extraction.
of this response is the interferon system which includes Anal. Biochem. 162, 156–159.
greater than 30 interferon-induced gene products. In re- Coccia, E. M., Krust, B., and Hovanessian, A. G. (1994). Specific inhibi-
tion of viral protein synthesis in HIV-infected cells in response tosponse, many viruses have evolved tactics to evade the
interferon treatment. J. Biol. Chem. 269, 23087–23094.antiviral effects of IFN (Samuel, 1993; Katze, 1993, 1995).
Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K.,The major target of viruses is the interferon-induced
Kanki, P. J., Essex, M., and Desoriers, R. C. (1985). Isolation of a T-
dsRNA-activated protein kinase PKR, which is activated cell tropic HTLV-III-like retrovirus from macaques. Science 228,
by viral RNAs and subsequently blocks viral (and cellular) 1201–1204.
Feinberg, A. P., and Voglestein, B. (1983). A technique for radiolabelingprotein synthesis. HIV-1 has evolved mechanisms to
DNA restriction endonuclease fragments to high specific activity.downregulate PKR through the action of the tat regulatory
Anal. Biochem. 132, 6–13.gene product (Roy et al., 1990). This regulation is essen-
Fernie, B. F., Poli, G., and Fauci, A. S. (1991). Alpha interferon sup-
tial since HIV-1 TAR containing RNAs can activate PKR presses virion but not soluble human immunodeficiency virus antigen
(Roy et al., 1991). Another potential target for viruses is production in chronically infected T-lymphocytic cells. J. Virol. 65,
3968–3971.the 2*,5* oligoadenylate synthetase which can activate
Hansen, B. D., Nara, P. L., Maheshwari, R. K., Sidhu, G. S., Bernbaum,another IFN-induced gene product, RNAse L (Hovanes-
J. G., Hoekzema, D., Meltzer, M. S., and Gendelman, H. E. (1995). Losssian, 1991). RNAse L has the capacity to inhibit virus
of infectivity by progeny virus from alpha interferon-treated human
replication by degrading viral RNAs (Zhou et al., 1993). immunodeficiency virus type 1-infected T cells is associated with
We found little evidence that HIV-1 replication in culture defective assembly of envelope gp120. J. Virol. 66, 7543–7548.
is inhibited by IFN through any of these defined path- Harada, S., Koyanagi, Y., and Yamamoto, N. (1985). Infection of HTLV-
III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application inways, providing additional proof that the virus has indeed
plaque assay. Science 229, 563–566.evolved successful strategies to counteract the detrimen-
Hovanessian, A. G. (1991). Interferon-induced and ds RNA activatedtal effects of these enzymes. There are only minor effects
enzymes: A specific protein kinase and 2*-5* oligodenylate synthe-
on mRNA translation and RNA accumulation is unaltered, tases. J. Interferon Res. 1, 199–205.
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